Leadership Team
Management Team
Under the leadership of Chief Executive Officer, Mr. Jean-Jacques Bienaimè, BioMarin’s executive management team includes accomplished leaders with deep and broad executive experience. Supported by a staff of approximately 800 employees worldwide, BioMarin is focused on delivering first-to-market therapies to patients with rare genetic diseases.
| Jean-Jacques Bienaimè Chief Executive Officer |
Daniel P. Maher Senior Vice President, Product Development |
| Stephen Aselage Executive Vice President and Chief Business Officer |
Joshua A. Grass Senior Vice President, Corporate and Business Development |
| Robert A. Baffi, Ph.D. Executive Vice President, Technical Operations |
Philip Lo Scalzo Vice President, Corporate Compliance and Ethics |
| Henry J. Fuchs, M.D. Executive Vice President and Chief Medical Officer |
Ed Von Pervieux Vice President and Chief Information Officer |
| Jeffrey H. Cooper Senior Vice President and Chief Financial Officer |
Mark Wood Senior Vice President, Human Resources and Corporate Affairs |
| G. Eric Davis Senior Vice President, General Counsel and Secretary |
Board of Directors
| Jean-Jacques Bienaimè Chief Executive Officer |
Pierre Lapalme Former President and Chief Executive Officer, Ethypharm, Inc., North America |
| Kenneth Bate 4 President and Chief Executive Officer, Archemix, Inc. |
V. Bryan Lawlis 4,5 President and Chief Executive Officer, Itero Biopharmaceuticals, Inc. |
| Michael Grey 5,6 Venture Partner, Pappas Ventures; President and Chief Executive Officer, Lumena Pharmaceuticals, Inc. |
Alan Lewis, Ph.D. 2 Chief Executive Officer and Director, Ambit Biosciences |
| Elaine
Heron 4,5,6 Chairman and Chief Executive Officer, Amplyx Pharmaceuticals, Inc. |
Richard
Meier 1 Executive Vice President and Chief Financial Officer, TeleFlex, Incorporated |
| William
Young 3 Venture Partner, Clarus Venture, San Francisco and Boston |
|
| 1 Chairman, Audit Committee 2 Chairman, Compensation Committee 3 Chairman, Corporate Governance and Nominating Committee 4 Member, Audit Committee 5 Member, Compensation Committee 6 Member, Corporate Governance and Nominating Committee |
|
Science Advisory Board
| Jeffrey Borer, M.D. Director, The Howard Gilman Institute for Valvular Heart Diseases Weill Medical College of Cornell University New York, New York |
Joseph Loscalzo, M.D., Ph.D. Chairman, Department of Medicine Brigham and Women's Hospital Boston, Massachusetts Editor in Chief, Circulation |
| Raymond C. Stevens, Ph.D. Professor of Molecular Biology & Chemistry The Scripps Research Institute La Jolla, California |
David L. Rimoin, M.D., Ph.D. Steven Spielberg Chair and Director, Medical Genetics Institute Director, International Skeletal Dysplasia Registry Cedar-Sinai Medical Center Los Angeles, California |
| Alan Lewis, Ph.D. Chief Executive Officer and Director, Ambit Biosciences |
Larry J. Shapiro, M.D. Spencer T. and Ann W. Olin Distinguished Professor Executive Vice Chancellor for Medical Affairs and Dean Washington University School of Medicine St. Louis, Missouri |
| Stephen L. Hauser, M.D. Robert A. Fishman Distinguished Professor and Chair of the Department of Neurology, UCSF |
|
